The Society of Infectious Diseases of Venezuela defended this Monday (11) that Cuban vaccines against Covid-19 (Abdala and Sovereign 2) should not be applied in the country until they have the authorization of recognized international and national regulatory agencies.
“We consider that the Abdala and Sovereign 2 vaccine candidates should not be administered as part of a mass vaccination schedule until they meet the corresponding scientific endorsement requirements, as indicated above,” the expert group said in a statement.
The association’s concern is due to the arrival in Venezuela of 900,000 doses of Abdala on the 3rd, after an authorization for its emergency use was approved in July by the Cuban State Control Center for Medicines (CECMED).
In the text, which was published on Twitter, the board of the Venezuelan association asked health authorities to “guarantee the immunization of the population with biological products of recognized efficacy and safety, with sufficient endorsement and recognition from various regulatory agencies, and with the corresponding scientific support “.
Probable use of vaccines in children in Venezuela criticized
The country’s Society of Infectious Diseases also referred to the pediatric “probable use” of some of the Cuban vaccines in Venezuela and emphasized that there is a lack of studies on the subject.
“The announcement of the likely use of these vaccine candidates in the pediatric population, as Cuba and Nicaragua are doing, is even more concerning. We reiterate that these vaccine candidates lack sufficient scientific support to be used in the population on a large scale, let alone to be currently used in children and adolescents,” said the association.
Recently, the National Academy of Medicine of Venezuela (ANM) also expressed “deep concern” with the use of Abdala, “a product for which there is no scientific information on its safety and efficacy”.
The ANM also denounced that “there are no known scientific publications” and no approval from the World Health Organization (WHO) “or any other international regulatory agency” regarding Abdala, whose vaccination schedule requires three doses.
The Society of Infectious Diseases of Venezuela defended this Monday (11) that Cuban vaccines against Covid-19 (Abdala and Sovereign 2) should not be applied in the country until they have the authorization of recognized international and national regulatory agencies.
“We consider that the Abdala and Sovereign 2 vaccine candidates should not be administered as part of a mass vaccination schedule until they meet the corresponding scientific endorsement requirements, as indicated above,” the expert group said in a statement.
The association’s concern is due to the arrival in Venezuela of 900,000 doses of Abdala on the 3rd, after an authorization for its emergency use was approved in July by the Cuban State Control Center for Medicines (CECMED).
In the text, which was published on Twitter, the board of the Venezuelan association asked health authorities to “guarantee the immunization of the population with biological products of recognized efficacy and safety, with sufficient endorsement and recognition from various regulatory agencies, and with the corresponding scientific support “.
Probable use of vaccines in children in Venezuela criticized
The country’s Society of Infectious Diseases also referred to the pediatric “probable use” of some of the Cuban vaccines in Venezuela and emphasized that there is a lack of studies on the subject.
“The announcement of the likely use of these vaccine candidates in the pediatric population, as Cuba and Nicaragua are doing, is even more concerning. We reiterate that these vaccine candidates lack sufficient scientific support to be used in the population on a large scale, let alone to be currently used in children and adolescents,” said the association.
Recently, the National Academy of Medicine of Venezuela (ANM) also expressed “deep concern” with the use of Abdala, “a product for which there is no scientific information on its safety and efficacy”.
The ANM also denounced that “there are no known scientific publications” and no approval from the World Health Organization (WHO) “or any other international regulatory agency” regarding Abdala, whose vaccination schedule requires three doses.
The Society of Infectious Diseases of Venezuela defended this Monday (11) that Cuban vaccines against Covid-19 (Abdala and Sovereign 2) should not be applied in the country until they have the authorization of recognized international and national regulatory agencies.
“We consider that the Abdala and Sovereign 2 vaccine candidates should not be administered as part of a mass vaccination schedule until they meet the corresponding scientific endorsement requirements, as indicated above,” the expert group said in a statement.
The association’s concern is due to the arrival in Venezuela of 900,000 doses of Abdala on the 3rd, after an authorization for its emergency use was approved in July by the Cuban State Control Center for Medicines (CECMED).
In the text, which was published on Twitter, the board of the Venezuelan association asked health authorities to “guarantee the immunization of the population with biological products of recognized efficacy and safety, with sufficient endorsement and recognition from various regulatory agencies, and with the corresponding scientific support “.
Probable use of vaccines in children in Venezuela criticized
The country’s Society of Infectious Diseases also referred to the pediatric “probable use” of some of the Cuban vaccines in Venezuela and emphasized that there is a lack of studies on the subject.
“The announcement of the likely use of these vaccine candidates in the pediatric population, as Cuba and Nicaragua are doing, is even more concerning. We reiterate that these vaccine candidates lack sufficient scientific support to be used in the population on a large scale, let alone to be currently used in children and adolescents,” said the association.
Recently, the National Academy of Medicine of Venezuela (ANM) also expressed “deep concern” with the use of Abdala, “a product for which there is no scientific information on its safety and efficacy”.
The ANM also denounced that “there are no known scientific publications” and no approval from the World Health Organization (WHO) “or any other international regulatory agency” regarding Abdala, whose vaccination schedule requires three doses.
The Society of Infectious Diseases of Venezuela defended this Monday (11) that Cuban vaccines against Covid-19 (Abdala and Sovereign 2) should not be applied in the country until they have the authorization of recognized international and national regulatory agencies.
“We consider that the Abdala and Sovereign 2 vaccine candidates should not be administered as part of a mass vaccination schedule until they meet the corresponding scientific endorsement requirements, as indicated above,” the expert group said in a statement.
The association’s concern is due to the arrival in Venezuela of 900,000 doses of Abdala on the 3rd, after an authorization for its emergency use was approved in July by the Cuban State Control Center for Medicines (CECMED).
In the text, which was published on Twitter, the board of the Venezuelan association asked health authorities to “guarantee the immunization of the population with biological products of recognized efficacy and safety, with sufficient endorsement and recognition from various regulatory agencies, and with the corresponding scientific support “.
Probable use of vaccines in children in Venezuela criticized
The country’s Society of Infectious Diseases also referred to the pediatric “probable use” of some of the Cuban vaccines in Venezuela and emphasized that there is a lack of studies on the subject.
“The announcement of the likely use of these vaccine candidates in the pediatric population, as Cuba and Nicaragua are doing, is even more concerning. We reiterate that these vaccine candidates lack sufficient scientific support to be used in the population on a large scale, let alone to be currently used in children and adolescents,” said the association.
Recently, the National Academy of Medicine of Venezuela (ANM) also expressed “deep concern” with the use of Abdala, “a product for which there is no scientific information on its safety and efficacy”.
The ANM also denounced that “there are no known scientific publications” and no approval from the World Health Organization (WHO) “or any other international regulatory agency” regarding Abdala, whose vaccination schedule requires three doses.